AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

Before you orderOffer from Amazon

Get beauty and skincare favorites delivered free with Prime

  • Fast, free delivery on millions of items
  • Prime Video, Amazon Music and more included
  • Member-only deals all year
Start your free Prime trial Free trial for eligible customers · Cancel anytime
As an affiliate, we earn on qualifying purchases.

LipoTrue introduced three cosmetic active ingredients—Glintarine, Red Aternaliss and Kalizyme—at in-cosmetics Asia 2026. The company says they target skin radiance, signs of aging and epidermal renewal; the source does not provide independent clinical data or detailed study methods to substantiate the stated benefits.

LipoTrue introduced three cosmetic active ingredients—Glintarine, Red Aternaliss and Kalizyme—at in-cosmetics Asia 2026, adding new options for formulators developing products focused on radiance, skin aging and epidermal renewal. The company describes the launches as biotechnology-based ingredients, but the available report does not include independent testing or study details supporting the performance claims.

The three ingredients take different approaches to cosmetic formulation. Glintarine is a marine ferment inspired by the sea surface microlayer, which the report describes as the interface between the ocean and light. LipoTrue says it is designed to influence melanin dynamics during epidermal renewal and combines depigmenting, exfoliating and antioxidant activities. The company reports visible results from the first week, though the source does not specify how that result was measured or in what study population.

Red Aternaliss combines Edelweiss stem cells and red algae extracts. LipoTrue positions it as a cellular longevity active and says it targets the nine Hallmarks of Aging, supporting genomic protection, regeneration, cellular resilience and epidermal integrity. These are the company’s descriptions of the ingredient’s intended activity; the source provides no details about clinical evidence, test methods or the extent of any observed effects.

Kalizyme is described as a biomimetic enzyme of human KLK7, produced using LipoTrue’s Wild Plants as Biofactories technology. The company says it is intended to support exfoliation and skin renewal while maintaining comfort. LipoTrue presented all three ingredients at booth V50 at the Asia event, which is aimed in part at industry professionals assessing ingredients for cosmetic products.

At a glance
announcementWhen: Announced at in-cosmetics Asia 2026
The developmentLipoTrue expanded its cosmetic active ingredient portfolio with three launches presented at in-cosmetics Asia 2026.

New Options for Cosmetic Formulators

The launches give cosmetic formulators three distinct ingredient concepts to consider: a marine-derived ferment for products positioned around even-looking skin, a plant-and-algae combination for aging-related product concepts, and an enzyme intended for gentle exfoliation. Their relevance is primarily to product development and ingredient sourcing, rather than evidence of a finished product or a change in consumer access to a particular treatment.

The announcement also illustrates how suppliers are presenting biotechnology alongside nature-derived materials. LipoTrue says the ingredients draw on marine biotechnology, plant-based technology and biomimetic science. For buyers and researchers, the next practical questions are likely to concern the evidence behind the claims, compatibility with formulations, safety data, recommended use levels and ingredient supply. Those details are not included in the available report.

Products Worth Considering

As an affiliate, we earn on qualifying purchases.

Three Routes to Skin Renewal

LipoTrue is expanding its portfolio of cosmetic active ingredients with the three launches at in-cosmetics Asia 2026. The company frames them as complementary approaches to skin performance, each linked to a different biological inspiration: the ocean’s surface layer for Glintarine, Edelweiss and red algae for Red Aternaliss, and the skin’s own desquamation process for Kalizyme.

The announcement is directed at formulators and cosmetics industry professionals seeking ingredients for product concepts around luminosity, healthy aging, exfoliation and the appearance of renewed skin. The source report identifies the ingredients and their intended roles, but does not supply a technical dossier, independent assessment or comparative data against existing cosmetic actives.

Evidence Behind the Performance Claims

The report does not provide clinical or instrumental study data for any of the three ingredients. It does not state the sample sizes, testing conditions, concentrations, study duration or criteria used to assess outcomes. In particular, LipoTrue’s statement that Glintarine can produce visible results from the first week is not accompanied by a defined endpoint or an explanation of how visibility was evaluated.

It is also unclear from the available material how the ingredients perform in finished formulations, what use levels are recommended, or what safety and regulatory documentation is available to prospective customers. The announcement describes intended cosmetic effects; it does not establish that the ingredients treat medical conditions or that every formulation containing them will produce the stated results.

Product Details After the Launch

LipoTrue presented the ingredients at booth V50 during in-cosmetics Asia 2026. The source does not give a later launch timetable, pricing, commercial availability, or dates for further technical disclosures. Formulators seeking to evaluate the actives will need product-specific information from the company, including formulation guidance, safety documentation and the evidence supporting its claims.

Further reporting would be needed to establish whether LipoTrue releases detailed performance data or whether brands announce finished products using Glintarine, Red Aternaliss or Kalizyme. Until such information is available, the confirmed development is the portfolio announcement and the company’s stated intended uses for the three ingredients.

Key Questions

What did LipoTrue announce?

LipoTrue introduced Glintarine, Red Aternaliss and Kalizyme, three cosmetic active ingredients, at in-cosmetics Asia 2026.

What is each ingredient intended to do?

LipoTrue positions Glintarine for radiance and even-looking skin, Red Aternaliss for products focused on skin aging, and Kalizyme for exfoliation and epidermal renewal. These are company-described cosmetic uses.

What is Kalizyme made with?

LipoTrue describes Kalizyme as a biomimetic enzyme of human KLK7, produced using its Wild Plants as Biofactories technology. The report does not provide further production or formulation specifications.

Are the reported benefits independently verified?

The source report does not include independent testing or detailed study data. It reports LipoTrue’s claims, including Glintarine’s stated first-week visible results, without providing methods or measurements.

Where were the ingredients presented?

LipoTrue presented the three launches at booth V50 at in-cosmetics Asia 2026. The report does not state when broader commercial availability begins.

Source: cosmeticsbusiness.com

Wellness content on this site is informational and not a substitute for professional medical guidance.
You May Also Like

212 VIP Rose Gift Set for an Early Fall Evening

Carolina Herrera 212 VIP Rose gift set layers champagne, rose and amber for early fall evenings, gifting and polished nights in.

How To Get Thicker Hair, According To Trichologists

Trichologists say genetics set hair thickness limits, but nutrition, scalp care and targeted supplements can help hair reach its natural best.

Medicube PDRN Serum Review & Amazon Prime Day Deal

Glamour UK retested Medicube’s PDRN Pink Peptide Serum for its Prime Day coverage, reporting on its formula, three-week trial and limits.

What Beauty Buyers From UK Retailers Boots And Lookfantastic Are Looking For In 2027

Lookfantastic buyers cite fragrance and makeup as major 2027 opportunities, while the available report provides no detailed Boots buyer comments.